Results 221 to 230 of about 148,463 (294)
The extracellular matrix drives guanylate production and protects pancreatic cancer cells from oxaliplatin-induced DNA damage. [PDF]
Efthymiou G +16 more
europepmc +1 more source
On why cancer cells require a great amount of glucose
Abstract The traditional thinking has been that cancer cells require a great amount of glucose to support their rapid growth, but the reality may be different. We have previously demonstrated that all cancer cells in The Cancer Genome Atlas harbor persistent Fenton reactions in their cytosol, which generate OH− ${\text{OH}}^{-}$ and ultimately kill the
Xuechen Mu +6 more
wiley +1 more source
Purine metabolism: a pan-cancer metabolic dysregulation across circulation and tissues. [PDF]
Yu M +9 more
europepmc +1 more source
Abstract Metabolic alterations and immune dysfunction within the gastric tumor microenvironment critically drive gastric cancer (GC) progression and therapeutic resistance. Although single‐cell RNA sequencing (scRNA‐seq) has unveiled cellular heterogeneity in GC, the metabolic landscapes of tumor cells and their interplay with immune components remain ...
Junjun Liu +7 more
wiley +1 more source
Digital twins for in vivo metabolic flux estimations in patients with brain cancer. [PDF]
Meghdadi B +20 more
europepmc +1 more source
Decreased purine ingestion, increased molybdenum ingestion, and the decline in amyotrophic lateral sclerosis on Guam. [PDF]
Bourke CA.
europepmc +1 more source
ABSTRACT Antibody‐drug conjugates (ADCs) are innovative drugs composed of cytotoxic molecules (payload) linked to antibodies, that selectively target and kill cancer cells upon internalization. In vivo, ADCs exist as intact molecules, naked antibodies, or released, unconjugated (linker‐)payload.
Pauline L. M. Buitelaar +4 more
wiley +1 more source
Temozolomide-Derived AIC Is Incorporated into Purine Synthesis in Glioblastoma. [PDF]
Sowers ML +9 more
europepmc +1 more source

